pharma · Acute Myeloid Leukemia · Breast Cancer
First People's Hospital
The First People's Hospital of Lianyungang
First People's Hospital is a pharma organization headquartered in SAN DIEGO, CA, CN. Primary therapeutic focus areas include Acute Myeloid Leukemia, Breast Cancer, Gastric Cancer, Multiple Myeloma, Esophageal Squamous Ce
SAN DIEGO, CA, CN HQ
NMPA registrant Type
Company details
- Status
- Public
- HQ
- SAN DIEGO, CA, CN
- Programs
- 1136
- Drugs
- 626
- Patents
- 123
Iparomlimab and Tuvonralimab combined with lenvatinib and SOX
Phase 2 · small molecule · Gastric or Gastroesophageal Junction Adenocarcinoma
Iparomlimab and Tuvonralimab combined with lenvatinib and SOX for Gastric or Gastroesophageal Junction Adenocarcinoma is a Phase 2 program (small_molecule) at The First People's Hospital of Lianyungang with 1 ClinicalTrials.gov record(s).
Internal code QL-GasC-QIBA-3011
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- The First People's Hospital of Lianyungang
- Phase
- Phase 2
- Modality
- small_molecule
- Indication
- Gastric or Gastroesophageal Junction Adenocarcinoma
- Status
- active
- Trials
- 1